Interaction between ALOX15 polymorphisms and coronary artery disease in North Indian population

References

• Ebrahimi M, Kazemi-Bajestani SMR, Ghayour Mobarhan M, Ferns GA. Coronary artery disease and its risk factors status in Iran: a review. Iran Red Crescent Med J. 2011;13(9):610–23.
   PubMed Web of Science ®Google Scholar
• Gupta R. Recent trends in coronary heart disease epidemiology in India. Indian Heart J. 2008;60(2suppl–B):B4–18.
   PubMedGoogle Scholar
• Mohan V, Deepa R, Shantirani S, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India. The Chennai urban population study (CUPS No.5). J Am Coll Cardiol. 2001;38(3):682–87.
   PubMed Web of Science ®Google Scholar
• Reddy KS. India wakes upto the threat of cardiovascular disease. J Am Coll Cardiol. 2007;50(14):1370–72.
   PubMed Web of Science ®Google Scholar
• Gupta R, Mohan I, Narula J. Trends in Coronary Heart Disease Epidemiology in India. Ann Glob Health. 2016;82(2):307–15.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet. 2004;364(9438):937–52.
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, Hastie C, Prabhakaran D, Dominczak AF. Genomic approaches to coronary artery disease. Indian J Med Res. 2010;132:567–78.
   PubMed Web of Science ®Google Scholar
• Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278(5):483–93.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317–25.
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med. 1992;43:219–25.
   PubMed Web of Science ®Google Scholar
• Yu XH, Fu YC, Zhang DW, Yin K, Tang CK. Foam cells in atherosclerosis. Clin Chim Acta. 2013;424:245–52.
   PubMed Web of Science ®Google Scholar
• Funk CD. Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26(6):1204–06.
   PubMed Web of Science ®Google Scholar
• Back M. Leukotriene signaling in atherosclerosis and ischemia. Cardiovasc Drugs Ther. 2009;23(1):41–48.
   PubMed Web of Science ®Google Scholar
• Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res. 2011;50(1):115–31.
   PubMed Web of Science ®Google Scholar
• Haeggstrom JZ, Wetterholm A. Enzymes and receptors in the leukotriene cascade. Cell Mol Life Sci. 2002;59(5):742–53.
   PubMed Web of Science ®Google Scholar
• Kuhn H, Thiele BJ. The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett. 1999;449(1):7–11.
   PubMed Web of Science ®Google Scholar
• Kuhn H. Biologic relevance of lipoxygenase isoforms in atherogenesis. Expert Rev Cardiovasc Ther. 2005;3(6):1099–110.
   PubMedGoogle Scholar
• Kuhn H, O’Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006;45(4):334–56.
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Stavniichuk R, Drel VR, Shevalye H, Vareniuk I, Nadler JL, Robert E, Schmidt RE. Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies. Am J Pathol. 2010;177(3):1436–47.
   PubMed Web of Science ®Google Scholar
• Whatling C, McPheat W, Herslof M. The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field. Expert Opin Investig Drugs. 2007;16(12):1879–93.
   PubMed Web of Science ®Google Scholar
• Wittwer J, Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids. 2007;77(2):67–77.
   PubMed Web of Science ®Google Scholar
• McCaskie PA, Beilby JP, Hung J, Chapman CM, McQuillan BM, Powell BL, Thompson PL, Palmer LJ. 15-Lipoxygenase gene variants are associated with carotid plaque but not carotid intima-media thickness. Hum Genet. 2008;123(5):445–53.
   PubMed Web of Science ®Google Scholar
• Haeggstrom JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111(10):5866–98.
   PubMed Web of Science ®Google Scholar
• Wuest SJ, Crucet M, Gemperle C, Loretz C, Hersberger M. Expression and regulation of 12/15-lipoxygenases in human primary macrophages. Atherosclerosis. 2012;225(1):121–27.
   PubMed Web of Science ®Google Scholar
• Assimes TL, Knowles JW, Priest JR, Basu A, Borchert A, Volcik KA, Grove ML, Tabor HK, Southwick A, Tabibiazar R, et al. A near null variant of 12/15-lox encoded by a novel snp in Alox15 and the risk of coronary artery disease. Atherosclerosis. 2008;198(1):136–44.
   PubMed Web of Science ®Google Scholar
• Hersberger M. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins. Clin Chem Lab Med. 2010;48(8):1063–73.
   PubMed Web of Science ®Google Scholar
• Hersberger M, Muller M, Marti-Jaun J, Heid IM, Coassin S, Young TF, Waechter V, Hengstenberg C, Meisinger C, Peters A, et al. No association of two functional polymorphisms in human Alox15 with myocardial infarction. Atherosclerosis. 2009;205(1):192–96.
   PubMed Web of Science ®Google Scholar
• Cyrus T, Praticò D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation. 2001;103(18):2277–82.
   PubMed Web of Science ®Google Scholar
• George J, Afek A, Shaish A, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk CD, Sigal E, Harats D. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation. 2001;104(14):1646–50.
   PubMed Web of Science ®Google Scholar
• Harats D, Shaish A, George J, Mary M, Hiroki K, Hana L, Elliott S. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2000;20(9):2100–05.
   PubMed Web of Science ®Google Scholar
• Kaer K, Speek M. Retroelements in human disease. Gene. 2013;518(2):231–41.
   PubMed Web of Science ®Google Scholar
• Spasovski V, Tosic N, Nikcevic G, Stojiljkovic M, Zukic B, Radmilovic M, Karan-Djurasevic T, Srzentic S, Colovic M, Pavlovic S. The influence of novel transcriptional regulatory element in intron 14 on the expression of janus kinase 2 gene in myeloproliferative neoplasms. J Appl Genet. 2013;54(1):21–26.
   PubMed Web of Science ®Google Scholar
• Burdon KP, Rudock ME, Lehtinen AB, Langefeld CD, Bowden DW, Register TC, Liu Y, Freedman BI, Carr JJ, Hedrick CC, et al. Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study. Mediators Inflamm. 2010;2010:170153.
   PubMed Web of Science ®Google Scholar
• Mochizuki N, Kwon YG. 15-lipoxygenase-1 in the vasculature: expanding roles in angiogenesis. Circ Res. 2008;102(2):143–45.
   PubMed Web of Science ®Google Scholar
• Van Hee VC, Adar SD, Szpiro AA, Barr RG, Diez Roux A, Bluemke DA, Sheppard L, Gill EA, Bahrami H, Wassel C, et al. Common genetic variation, residential proximity to traffic exposure, and left ventricular mass: the multiethnic study of atherosclerosis. Environ Health Perspect. 2010;118(7):962–69.
   PubMed Web of Science ®Google Scholar
• Zhang K, Wang YY, Liu QJ, Wang H, Liu FF, Ma ZY, Gong YQ, Li L. Two single nucleotide polymorphisms in ALOX15 are associated with risk of coronary artery disease in a Chinese Han population. Heart Vessels. 2010;25(5):368–73.
   PubMed Web of Science ®Google Scholar
• Zhao J, He Z, Ma S, Li L. Association of ALOX15 gene polymorphism with ischemic stroke in northern Chinese Han population. J Mol Neurosci. 2012;47(3):458–64.
   PubMed Web of Science ®Google Scholar
• Roe BA, Crabtree JS, Khan AS. DNA isolation and sequencing. In: Rickwood D, editor. Essential techniques series. Vol. 85–86. New York, NY: John Wiley and Sons; 1996, p. 116–17.
   Google Scholar
• Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004;18:73–78.
   PubMed Web of Science ®Google Scholar
• Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: indian scenario. Indian J Med Res. 2007;125:217–30.
   PubMed Web of Science ®Google Scholar
• Prabhakaran D, Chaturvedi V, Shah P, Manhapra A, Jeemon P, Shah B, Srinath Reddy K. Differences in the prevalence of metabolic syndrome in urban and rural India: a problem of urbanization. Chronic Illness. 2007;3:8–19.
   PubMedGoogle Scholar
• Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia (Rapid Response). Bmj. 2004;328:807–10.
   PubMed Web of Science ®Google Scholar
• Deaton A, Dreze J. Food and Nutrition in India: facts and interpretation. Econ Political Wkly. 2009;44:42e65.
   Google Scholar
• Cleveland Clinic. Smoking & heart disease (2014).
   Google Scholar
• Verma P, Verma DK, Sethi R, Singh S, Krishna A. The rs2070895 (−250G/A) single nucleotide polymorphism in Hepatic Lipase (HL) gene and the risk of coronary artery disease in North Indian population: A case-control study. J Clin Diagn Res. 2016;10(8):GC01–6.
   PubMed Web of Science ®Google Scholar
• Gaeta G, DeMichele M, Cuomo S, Guarini P, Foglia MC, Bond MG, Trevisan M. Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med. 2000;343(12):840–46.
   PubMed Web of Science ®Google Scholar
• Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke. 2005;36(1):5–8.
   PubMed Web of Science ®Google Scholar
• Hunt DR, Goring H, Williams JT, Almasy L, Blangero J, O’Leary DH, Stern M. Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study. Stroke. 2002;33(12):2775–80.
   PubMed Web of Science ®Google Scholar
• Lange LA, Lange EM, Bielak LF, Langefeld CD, Kardia SL, Royston P, Turner ST, Sheedy PF, 2nd, Boerwinkle E, Peyser PA. Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler Thromb Vasc Biol. 2002;22(3):418–23.
   PubMed Web of Science ®Google Scholar
• Xiang AH, Azen SP, Buchanan TA, Raffel LJ, Tan S, Cheng LS, Diaz J, Toscano E, Quinonnes M, Liu CR, et al. Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arterioscler Thromb Vasc Biol. 2002;22(5):843–48.
   PubMed Web of Science ®Google Scholar
• Duggirala R, Gonzalez C, O’Leary DH, Stern MP, Blangero J. Genetic basis of variation in carotid artery wall thickness. Stroke. 1996;27(5):833–37.
   PubMed Web of Science ®Google Scholar
• Assimes TL, Knowles JW, Priest JR, Basu A, Volcik KA, Southwick A, Tabor HK, Hartiala J, Allayee H, Grove ML, et al. Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet. 2008;123(4):399–408.
   PubMed Web of Science ®Google Scholar
• Camacho M, Martinez-Perez A, Buil A, Siguero L, Alcolea S, López S, Fontcuberta J, Souto JC, Vila L, Soria JM. Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular risk. Atherosclerosis. 2012;224(1):129–35.
   PubMed Web of Science ®Google Scholar
• Crosslin DR, Shah SH, Nelson SC, Haynes CS, Connelly JJ, Gadson S, Goldschmidt-Clermont PJ, Vance JM, Rose J, Granger CB, et al. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum Genet. 2009;125(2):217–29.
   PubMed Web of Science ®Google Scholar
• Girelli D, Martinelli N, Trabetti E, Olivieri O, Cavallari U, Malerba G, Busti F, Friso S, Pizzolo F, Pignatti PF, et al. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study. Eur J Hum Genet. 2007;15(9):959–66.
   PubMed Web of Science ®Google Scholar
• Hartiala J, Li D, Conti DV, Vikman S, Patel Y, Tang WH, Brennan M-L, Newman JW, Stephensen CB, Armstrong P, et al. Genetic contribution of the leukotriene pathway to coronary artery disease. Hum Genet. 2011;129(6):617–27.
   PubMed Web of Science ®Google Scholar
• Helgadottir A, Gretarsdottir S, St Clair D, Manolescu A, Cheung J, Thorleifsson G, Pasdar A, Grant SF, Whalley LJ, Hakonarson H, et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet. 2005;76(3):505–09.
   PubMed Web of Science ®Google Scholar
• Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A, et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet. 2006;38(1):68–74.
   PubMed Web of Science ®Google Scholar
• Linsel-Nitschke P, Gotz A, Medack A, Konig IR, Bruse P, Lieb W, Mayer B, Stark K, Hengstenberg C, Fischer M, et al. Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population. Clin Sci (Lond). 2008;115(10):309–15.
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier JP. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 2003;62(6):501–09.
   PubMed Web of Science ®Google Scholar
• Natarajan R, Nadler JL. Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol. 2004;24(9):1542–48.
   PubMed Web of Science ®Google Scholar
• Werz O, Steinhilber D. Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol Ther. 2006;112(3):701–18.
   PubMed Web of Science ®Google Scholar